Status:
UNKNOWN
Myo-inositol Administration in Gestational Diabetes
Lead Sponsor:
University of Messina
Conditions:
Gestational Diabetes Mellitus
Eligibility:
FEMALE
18-44 years
Phase:
NA
Brief Summary
Myo-Inositol is an insulin sensitizing agent that ameliorate the insulin resistance in women affected by gestational diabetes (GDM), but there is no information about the effect on the glucose profile...
Detailed Description
Our study is a randomized, prospective, controlled trial, including the first 30 consecutive Caucasian gestational diabetes patients diagnosed,according the International Association of Diabetes and P...
Eligibility Criteria
Inclusion
- Gestational diabetes diagnosed within 28 weeks
- Caucasian pregnant women
Exclusion
- Non Caucasian pregnant women
- Delivery before 8 weeks of treatment
Key Trial Info
Start Date :
November 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00734448
Start Date
November 1 2013
End Date
December 1 2014
Last Update
June 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Messina -
Messina, Sicily, Italy, 98100